Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck

Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck

Recurrent metastatic (RM) and locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) are devasting disease states with limited therapeutic options and poor overall survival. Targeting the epidermal growth factor receptor (EGFR) is one area that has helped improve outcomes in this...

Full description

Bibliographic Details
Main Authors: Bhamini Patel, Nabil F. Saba
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
head and neck squamous cell carcinoma
EGFR inhibition in head and neck cancer
combination immunotherapy and EGFR in head and neck cancer
EGFR monoclonal antibodies
EGFR and chemotherapy in SCCHN
Epidermal Growth Factor and squamous cell carcinoma
Online Access:https://www.mdpi.com/2072-6694/13/14/3545

Similar Items

Similar Items